The North West province has become the first province in the country to cure a patient who was suffering from Extremely Drug Resistant (XDR) Tuberculosis (TB).
Provincial Department of Health spokesperson Tebogo Lekgethwane announced on Tuesday that the department recorded the first case in the middle of last year, but had to wait for a confirmation from the national department that the patient had not lapsed.
"We are happy to announce that we are the first province to successfully cure XDR TB. The national department of health's Communicable Disease Directorate only confirmed this at the beginning of March because the patient was still being monitored to make sure he does not lapse," said Lekgethwane.
HIV may be the most immediate threat to healthcare in the country but health data gathered from hospitals around the country shows that violence and lifestyle diseases are taking a grievous toll on the health system.
The District Health Barometer, released in Pretoria on Thursday alongside the latest edition of the South African Health Review, showed that outside of HIV/Aids and opportunistic infections associated with it, such as tuberculosis (TB), pneumonia and diarrhoeal disease, the leading cause of premature death in the country is transport injury.
Health MEC Fezi Ngubentombi and her department kicked off the 2011-2012 financial year on a high note, promising to revitalise the health sector and inject new funds in the health sector that previously saw hospitals and clinics running out of essential drugs.
As a starting point, she promised to launch or relaunch forums that she saw as vital partners in the provision of health in the province, and more importantly, the Traditional Healers Forum and the district health councils of Lejweleputswa, Motheo and Thabo Mofutsanyana, as well as breathe new life into hospital boards and clinic committees of the same districts, among others.
The head of the Global Fund, the largest backer of the fight against AIDS, tuberculosis and malaria, will step down in March after a misuse of funds led it to cut back on new grants to battle the diseases.
Michel Kazatchkine has been the Global Fund's executive director for five years, half its life, but was sidelined in November after the organisation said it would be forced to cut grants and was bringing in a new manager.
The Fund said it had appointed Gabriel Jaramillo, a Brazilian former banker, as general manager.
The public-private Global Fund, based in Geneva, accounts for around a quarter of international financing to fight HIV and AIDS, as well as the majority of funds to fight TB and malaria.
THE department of health in KwaZulu-Natal planned to fast-track infrastructure development and hospital revitalisation projects this year, health MEC Sibongiseni Dhlomo said yesterday.
The province suffers from a disproportionately high incidence of HIV/AIDS and tuberculosis, and has a large rural population, many of whom live a long way from proper healthcare facilities.
Dr Dhlomo said this year would be groundbreaking for the healthcare sector nationally as "we will be introducing the long-awaited National Health Insurance (NHI) scheme ".
He said districts had social mobilisation and communication plans to popularise the NHI at community levels, while the hospital management programme would be fast-tracked.
The Millennium Challenge Corporation (MCC), through its partnership with the Millennium Challenge Account–Lesotho, is helping Lesotho address key challenges in its health sector through a $122 million investment in health infrastructure and health systems.
More than 720,000 Basotho are expected to benefit from the MCC health project over the next 20 years. MCC described the ways its investment in health is helping in Lesotho in a December 1 press release.
Ten years ago, the Doha Declaration allowed countries to circumvent patent rights to access life-saving medicines, particularly those used to treat HIV/AIDS, tuberculosis and malaria. However, the South African government has failed to take advantage of these provisions, and increasingly important TB medication and second- and third-line antiretrovirals (ARVs) remain out of reach, activists warn.
"Pre-Doha, treating [HIV] without generics... meant HIV was a death sentence," said Gilles van Cutsem, medical coordinator for Médecins Sans Frontières (MSF).
Years of treatment and mounds of pills are hard work for older patients with multidrug resistant tuberculosis (MDR-TB), but in children, treatment becomes a minefield for patients and doctors alike.
MDR-TB is resistant to the most powerful drugs used to treat active TB, rifampicin and isoniazid. With weaker immune systems, children who contract TB - most often from parents - progress to active disease in about a year. But just how many children are affected is not known as there is almost no research into children and MDR-TB - and very little useful guidance on how to treat them.
Home-based tuberculosis (TB) education and testing reduced community TB prevalence by about 20 percent, according to findings of a large, two-country study released at the International Lung Health Conference in Lille, France.
Conducted among almost 963,000 people in Zambia and South Africa, the ZAMSTAR study rolled out household education and TB testing to some communities while others received enhanced TB case detection, which included activities such as community dramas to raise TB awareness.
This is the sixteenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and ﬁnancing TB prevention, care and control at global, regional and country levels using data reported by 198 countries that account for over 99% of the world’s TB cases.